$REVBOct 16, 2026, 9:00 AM ETAI processed
REVB to implement 1-for-7 reverse stock split effective Oct 20 to regain Nasdaq compliance
AI Summary
Revelation Biosciences (REVB) will implement a 1-for-7 reverse stock split effective the morning of Oct 20, 2026 to increase its per-share price and regain compliance with The Nasdaq Capital Market minimum bid requirement; shares will continue trading under the symbol REVB post-split. Warrants, RSUs and options will be proportionally adjusted, fractional shares will be rounded up to whole shares, registered holders need take no action, and broker-held positions will be adjusted per each broker's process.
Positives
- Action intended to restore compliance with Nasdaq minimum bid requirement
- Fractional shares resulting from the split will be rounded up to the nearest whole share
- Registered holders are not required to take action; positions will be adjusted automatically
Negatives
- Reverse split signals the company’s share price was below Nasdaq’s minimum bid, indicating delisting risk prior to the action
- Proportionate adjustments to warrants, options and RSUs will change per-share economics for those security holders